Find a Doctor - Search by last name or narrow your search by gender or languages spoken
Find a Location - Search by specialty, city, or state
Oral (by mouth)
| Generic Name | Brand Name |
|---|---|
| gold/auranofin | Ridaura |
Intramuscular (by a shot or injection)
| Generic Name | Brand Name |
|---|---|
| gold aurothioglucose | Solganal |
| gold sodium thiomalate | Aurolate, Myochrysine |
It is not understood exactly how gold works to treat rheumatoid arthritis. But gold salts appear to accumulate slowly in the body and, over time, they reduce inflammation and slow the progression of rheumatoid arthritis.
Gold injections are given every week for the first 22 weeks. After that, gold may be given less often if it is working.1
Gold is used to reduce inflammation and slow disease progression in people with rheumatoid arthritis. Gold is not usually the first treatment given to people with rheumatoid arthritis, since methotrexate and other disease-modifying antirheumatic drugs (DMARDs) are available.
A review reports that treatment with intramuscular gold (parenteral gold) reduces disease activity and joint inflammation.2
Gold salts taken by mouth (oral) have not been found to be as effective as gold injections, and it can take up to 6 months before benefits are noticed from oral gold salts.1
Side effects may develop after a significant amount of gold has accumulated in the body.
Oral gold has fewer side effects than gold injected into the muscle. Common side effects of oral gold include:
Common side effects of injected gold include:
Rarer side effects include:
Extremely rare side effects include bowel or lung inflammation.
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
It can take 3 to 6 months before gold treatment improves symptoms.
Regular urine tests to check for protein (indicating kidney damage) and blood tests are needed.
Complete the new medication information form (PDF)(What is a PDF document?) to help you understand this medication.
Last Revised: June 11, 2010
Author: Healthwise Staff
Medical Review: Anne C. Poinier, MD - Internal Medicine & Stanford M. Shoor, MD - Rheumatology
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
RT @drdavidpearce: Early trigger for #alzheimers http://t.co/aQnGFDHYnT reported might be a target for #neurodegenerative & #rarediseases